Value driven Adaptation in Radiation Oncology

 

Chairs: 

• Richard Canters, Medical Physicist, Maastro Clinic, Maastricht (NL)

• Lone Hoffmann, Medical Physicist, Aarhus University Hospital, Aarhus (DK)

• Ditte Sloth Møller, Medical Physicist, Aarhus University Hospital, Aarhus (DK)

Invited speakers: 

To be confirmed

 

Motivation:

Treatment adaptation, either online or offline, is a subject that the RO community puts much effort into, both financially and in terms of personnel. As an addition to this effort, we propose to use more quantitative tools such as dose-based metrics or TCP/NTCP models to evaluate the need for adaptation and the expected clinical benefit of adaptation, both on a cohort basis as well as on a patient during his/her treatment. To achieve this, existing tools such as reliable dose summation, TCP/NTCP models can be combined.

In this workshop, we will focus on the following topics:

• How to use TCP and NTCP models to generate quantitative criteria and guidelines for adaptation
• Clinical procedures in ART
• Deformable dose accumulation
• Evaluation of the benefit of ART per patient and on a cohort basis
• What needs are there from the field for vendors and vice versa
• Dosimetric and clinical data collection and validation of the benefit of ART both in terms of outcome and costs
• Online versus offline ART: what is the clinical benefit of each of them vs workload and costs

 

The workshop will bring together physicists who are actively involved in ART in clinical a setting and representatives from vendors to actively discuss the challenges and opportunities in value driven ART.

 

Potential outcomes:

With this workshop, we aim to reach the following goals:

• Generate a practice change in the application of ART, possibly through the creation of a consensus paper about implementation of ART in a value based manner
• Collaboration on the creation of especially TCP models through retrospective and prospective studies.